AVIR 3.16 (+0.64%)
US04683R1068BiotechnologyBiotechnology

Atea Pharmaceuticals (AVIR) Stock Highlights

3.16 | +0.64%
2024-11-21 05:07:06
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing therapies to address the unmet medical needs of patients with severe viral diseases. Its programs are focused on the development of orally- administered direct acting antivirals for the treatment of patients with COVID-19 in the hospital and community settings, the treatment of patients with chronic hepatitis C infection, the treatment of patients with dengue, and the treatment of high-risk patients with severe respiratory syncytial virus infection. The companys medicinal chemistry, virology, and pharmacology expertise, bolstered by its collective experience in drug development, enables it to pioneer new advancements in antiviral science.

Statistics

Range Today
3.1 3.16
Volume Today 182K
Range 1 Year
2.77 4.6
Volume 1 Year 77.61M
Range 3 Year
2.77 9.79
Volume 3 Year 416.88M
Range 10 Year
2.77 94.17
Volume 10 Year 885.42M

Highlights

Market Capitalization 295.62M (small)
Floating Shares 64.3M
Current Price 3.16
Price To Earnings -1.66
Price To Book 0.64
Earnings Per Share -2.1
Payout Ratio 0%

Performance

Latest +0.64%
1 Month -17.28%
3 Months -16.84%
6 Months -12.95%
1 Year +4.29%
3 Years -60.75%
5 Years -88.31%
10 Years -88.31%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.